Copyright
©The Author(s) 2004.
World J Gastroenterol. Jun 1, 2004; 10(11): 1634-1638
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1634
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1634
Group | Number | Hydroxyproline (mg/g liver) | Collagen I | Collagen III |
Disease control group | 10 | 0.296 ± 0.026d | 1209.44 ± 116.60d | 1175.14 ± 121.44d |
Antisense TβR II group | 10 | 0.167 ± 0.009bd | 650.26 ± 51.51bd | 661.58 ± 55.28bd |
Antisense TβR I group | 10 | 0.169 ± 0.015d | 669.90 ± 50.67d | 657.29 ± 49.48d |
pcDNA3 control group | 10 | 0.284 ± 0.025d | 1205.70 ± 110.11d | 1149.89 ± 91.61d |
Normal control group | 6 | 0.128 ± 0.004 | 449.33 ± 35.95 | 421.15 ± 20.15 |
- Citation: Jiang W, Yang CQ, Liu WB, Wang YQ, He BM, Wang JY. Blockage of transforming growth factor β receptors prevents progression of pig serum-induced rat liver fibrosis. World J Gastroenterol 2004; 10(11): 1634-1638
- URL: https://www.wjgnet.com/1007-9327/full/v10/i11/1634.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i11.1634